Underrepresentation of the elderly in clinical trials, time for action-Reference-Cited by-同舟云学术

Underrepresentation of the elderly in clinical trials, time for action

Published:2020-09-09 Issue:10 Volume:86 Page:2014-2016
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Marum Rob J.¹²³^ORCID

Affiliation:

1. Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute Amsterdam UMC, location VUmc Amsterdam The Netherlands

2. Departments of Clinical Pharmacology and Geriatrics Jeroen Bosch Hospital 's‐Hertogenbosch the Netherlands

3. Medicines Evaluation Board Utrecht the Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14539

Reference16 articles.

1. European Union.Eurostat statistics explained. Medicine use statistics2014https://ec.europa.eu/eurostat/statistics-explained/index.php/Medicine_use_statistics#Prescribed_medicines

2. Prescribing medicines to older people—how to consider the impact of ageing on human organ and body functions;Drenth‐van Maanen AC;Br J Clin Pharmacol,2019

3. Adverse drug reactions in special populations - the elderly

4. WHO Clinical Consortium on Healthy Ageing.Topic focus: frailty and intrinsic capacity. Report of consortium meeting 1–2 December 2016 in Geneva Switzerland.https://apps.who.int/iris/bitstream/handle/10665/272437/WHO-FWC-ALC-17.2-eng.pdf

5. Prevalence of Frailty in Community-Dwelling Older Persons: A Systematic Review

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. It takes a village: A multi-brain approach to studying multigenerational family communication;Developmental Cognitive Neuroscience;2024-02

2. Frailty in acute coronary syndromes. A systematic review and narrative synthesis of frailty assessment tools and interventions from randomised controlled trials;International Journal of Cardiology;2024-01

3. Recent advances in dosage form design for the elderly: a review;Expert Opinion on Drug Delivery;2023-11-02

4. Representation of older patients in the safety analysis of protein kinase inhibitor registration studies;Journal of Geriatric Oncology;2023-11

5. Development of geriatric oncology in Latin America: A report from the Latin American Cooperative Oncology Group;Journal of Geriatric Oncology;2023-11